Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Net Margin: 2017-2025

Historic Net Margin for Assembly Biosciences (ASMB) over the last 6 years, with Sep 2025 value amounting to -85.23%.

  • Assembly Biosciences' Net Margin rose 5520.00% to -85.23% in Q3 2025 from the same period last year, while for Sep 2025 it was -99.94%, marking a year-over-year increase of 3679.00%. This contributed to the annual value of -140.87% for FY2024, which is 71391.00% up from last year.
  • Per Assembly Biosciences' latest filing, its Net Margin stood at -85.23% for Q3 2025, which was up 6.95% from -91.61% recorded in Q2 2025.
  • Assembly Biosciences' 5-year Net Margin high stood at -85.23% for Q3 2025, and its period low was -300.66% during Q3 2021.
  • In the last 3 years, Assembly Biosciences' Net Margin had a median value of -123.41% in 2024 and averaged -120.96%.
  • As far as peak fluctuations go, Assembly Biosciences' Net Margin slumped by 29,098bps in 2021, and later soared by 6,329bps in 2025.
  • Over the past 4 years, Assembly Biosciences' Net Margin (Quarterly) stood at -300.66% in 2021, then reached -153.04% in 2023, then surged by 1,256bps to -140.48% in 2024, then skyrocketed by 5,520bps to -85.23% in 2025.
  • Its Net Margin was -85.23% in Q3 2025, compared to -91.61% in Q2 2025 and -93.62% in Q1 2025.